These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38059752)

  • 41. Gut microbiota does not play a mediating role in the causal association between inflammatory bowel disease and several its associated extraintestinal manifestations: a Mendelian randomization study.
    Lu W; Cen J; Dai Q; Tao H; Peng L
    Front Immunol; 2023; 14():1296889. PubMed ID: 38288127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area.
    Balvers M; Deschasaux M; van den Born BJ; Zwinderman K; Nieuwdorp M; Levin E
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus.
    Ren Y; Hao L; Liu J; Wang P; Ding Q; Chen C; Song Y
    mSystems; 2023 Apr; 8(2):e0114622. PubMed ID: 36853013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity.
    Joo M; Nam S
    BMC Microbiol; 2024 Jul; 24(1):268. PubMed ID: 39030520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbiota based personalized nutrition improves hyperglycaemia and hypertension parameters and reduces inflammation: a prospective, open label, controlled, randomized, comparative, proof of concept study.
    Kallapura G; Prakash AS; Sankaran K; Manjappa P; Chaudhary P; Ambhore S; Dhar D
    PeerJ; 2024; 12():e17583. PubMed ID: 38948211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Following the Indian Immigrant: adoption of westernization results in a western gut microbiome and an increased risk of inflammatory bowel diseases.
    D'Aloisio LD; Shetty V; Ballal M; Gibson DL
    FEMS Microbiol Ecol; 2022 Nov; 98(12):. PubMed ID: 36370451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges.
    Yan J; Wang L; Gu Y; Hou H; Liu T; Ding Y; Cao H
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
    Chehoud C; Albenberg LG; Judge C; Hoffmann C; Grunberg S; Bittinger K; Baldassano RN; Lewis JD; Bushman FD; Wu GD
    Inflamm Bowel Dis; 2015 Aug; 21(8):1948-56. PubMed ID: 26083617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Underdevelopment of the gut microbiota and bacteria species as non-invasive markers of prediction in children with autism spectrum disorder.
    Wan Y; Zuo T; Xu Z; Zhang F; Zhan H; Chan D; Leung TF; Yeoh YK; Chan FKL; Chan R; Ng SC
    Gut; 2022 May; 71(5):910-918. PubMed ID: 34312160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota and inflammatory bowel disease.
    Chen L; Wang J
    WIREs Mech Dis; 2022 Mar; 14(2):e1540. PubMed ID: 35266651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases.
    Somineni HK; Weitzner JH; Venkateswaran S; Dodd A; Prince J; Karikaran A; Sauer CG; Abramowicz S; Zwick ME; Cutler DJ; Okou DT; Chopra P; Kugathasan S
    Inflamm Bowel Dis; 2021 Nov; 27(12):1889-1900. PubMed ID: 34002220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases.
    Li H; Christman LM; Li R; Gu L
    Food Funct; 2020 Jun; 11(6):4878-4891. PubMed ID: 32490857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urbanization and the gut microbiota in health and inflammatory bowel disease.
    Zuo T; Kamm MA; Colombel JF; Ng SC
    Nat Rev Gastroenterol Hepatol; 2018 Jul; 15(7):440-452. PubMed ID: 29670252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients.
    Brand EC; Klaassen MAY; Gacesa R; Vich Vila A; Ghosh H; de Zoete MR; Boomsma DI; Hoentjen F; Horjus Talabur Horje CS; van de Meeberg PC; Willemsen G; Fu J; Wijmenga C; van Wijk F; Zhernakova A; Oldenburg B; Weersma RK;
    Gastroenterology; 2021 May; 160(6):1970-1985. PubMed ID: 33476671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metagenome-scale community metabolic modelling for understanding the role of gut microbiota in human health.
    Beura S; Kundu P; Das AK; Ghosh A
    Comput Biol Med; 2022 Oct; 149():105997. PubMed ID: 36055158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alterations in gut and genital microbiota associated with gynecological diseases: a systematic review and meta-analysis.
    Zhou Z; Feng Y; Xie L; Ma S; Cai Z; Ma Y
    Reprod Biol Endocrinol; 2024 Jan; 22(1):13. PubMed ID: 38238814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial.
    Zhang X; Ren H; Zhao C; Shi Z; Qiu L; Yang F; Zhou X; Han X; Wu K; Zhong H; Li Y; Li J; Ji L
    Diabetologia; 2022 Oct; 65(10):1613-1626. PubMed ID: 35930018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.